GeneReach Biotechnology Market Cap

GeneReach Biotechnology has a market cap or net worth of 1.31 billion as of June 18, 2025. Its market cap has decreased by -28.35% in one year.

Market Cap

1.31B

Enterprise Value

1.12B

Revenue

213.05M

Ranking

n/a

PE Ratio

n/a

Stock Price

22.90

Market Cap Chart

Since November 19, 2012, GeneReach Biotechnology's market cap has increased from 1.27B to 1.31B, an increase of 2.72%. That is a compound annual growth rate of 0.21%.

Market Cap History

Date	Market Cap	% Change
Jun 17, 2025	1.31B	-20.59%
Dec 31, 2024	1.65B	-27.38%
Dec 29, 2023	2.27B	-25.28%
Dec 30, 2022	3.03B	-20.04%
Dec 30, 2021	3.79B	-27.82%
Dec 31, 2020	5.26B	91.85%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	175.63B
Caliway Biopharmaceuticals	170.61B
Bora Pharmaceuticals Co., LTD.	82.65B
Lotus Pharmaceutical	57.45B
Oneness Biotech	34.39B
Polaris Group	30.28B
Center Laboratories	27.39B
Lumosa Therapeutics	27.26B

Market Cap Rankings